Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | RETA | EXEL | CYTK | ||
Company | Reata Pharma | Exelixis Inc | Cytokinetics | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 172.34 | 22.65 | 56.88 | ||
High | 172.46 | 22.74 | 57.69 | ||
Low | 172.32 | 22.44 | 55.66 | ||
Last | 172.36 | 22.69 | 57.18 | ||
Change | +0.04 | +0.09 | +0.77 | ||
% Change | +0.02% | +0.40% | +1.37% | ||
Volume | 1,988,500 | 304,597 | 577,856 | ||
20-Day Average Volume | 810,510 | 1,306,681 | 1,498,957 | ||
Previous Close | 172.32 | 22.60 | 56.41 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 170.84 | 22.36 | 55.25 | ||
20-Day Raw Stochastic | 97.36% | 66.07% | 76.98% | ||
20-Day Relative Strength | 81.56% | 55.58% | 52.88% | ||
Weighted Alpha | +177.60 | +11.00 | -0.74 | ||
Today's Opinion | 100% Buy | 40% Buy | 24% Sell | ||
Previous Opinion | 100% Buy | 40% Buy | 24% Sell | ||
Last Month's Opinion | 100% Buy | 56% Sell | 56% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.18% since 09/18/23 | +0.04% since 07/15/24 | -0.68% since 07/15/24 | ||
Low | 171.96 on 09/19/23 | 22.35 on 07/17/24 | 54.97 on 07/17/24 | ||
High | 172.46 on 09/25/23 | 22.94 on 07/16/24 | 58.85 on 07/16/24 | ||
1-Month | |||||
%Chg | +1.99% since 08/25/23 | +1.62% since 06/21/24 | +6.50% since 06/21/24 | ||
Low | 168.67 on 09/05/23 | 21.82 on 07/03/24 | 50.81 on 06/26/24 | ||
High | 172.46 on 09/25/23 | 22.94 on 07/16/24 | 58.85 on 07/16/24 | ||
3-Month | |||||
%Chg | +83.77% since 06/23/23 | -1.36% since 04/22/24 | -14.01% since 04/22/24 | ||
Low | 88.80 on 06/27/23 | 20.14 on 05/29/24 | 46.25 on 05/28/24 | ||
High | 172.46 on 09/25/23 | 23.89 on 04/29/24 | 68.76 on 04/23/24 | ||
6-Month | |||||
%Chg | +101.14% since 03/24/23 | -0.35% since 01/22/24 | -31.89% since 01/22/24 | ||
Low | 76.54 on 05/10/23 | 20.01 on 02/12/24 | 46.25 on 05/28/24 | ||
High | 172.46 on 09/25/23 | 24.07 on 03/21/24 | 84.92 on 01/23/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 6,575,535 | 6,852,321 | 5,914,814 | ||
Shares Outstanding, K | 38,150 | 303,200 | 104,854 | ||
Annual Sales | 2,220,000 | 1,830,210,000 | 7,530,000 | ||
Annual Net Income | -311,900,000 | 207,770,000 | -526,240,000 | ||
Last Quarter Sales | 22,750,000 | 425,230,000 | 840,000 | ||
Last Quarter Net Income | 193,000,000 | 37,320,000 | -135,640,000 | ||
60-Month Beta | 1.42 | 0.54 | 0.75 | ||
Per-Share Information | |||||
Most Recent Earnings | -2.32 on 08/08/23 | 0.17 on 04/30/24 | -1.33 on 05/08/24 | ||
Latest Earnings Date | 11/14/23 | 08/06/24 | 08/01/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 35.25 | 0.00 |